Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $662.37 billion, total revenue of $165.59 billion and a weighted average PE ratio of 37.67.
Market Cap
662.37B
Revenue
165.59B
Profits
17.58B
PE Ratio
37.67
Profit Margin
10.62%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 181.35B | -0.67% | 1,473,647 | 44.56B |
| 2 | DHR | Danaher Corporation | 135.96B | 0.52% | 2,595,436 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.98B | 1.39% | 588,419 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.45B | -0.55% | 1,153,763 | 7.07B |
| 5 | WAT | Waters Corporation | 29.83B | -0.05% | 652,236 | 3.17B |
| 6 | NTRA | Natera, Inc. | 29.04B | -1.50% | 808,762 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 28.66B | -1.47% | 1,155,234 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.65B | 0.53% | 88,399 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.62B | 0.27% | 421,450 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.86B | 0.91% | 477,714 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 19.53B | 0.28% | 1,033,917 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 14.16B | -0.47% | 294,134 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.76B | -4.44% | 1,066,545 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.87B | -0.70% | 624,431 | 2.86B |
| 15 | QGEN | Qiagen N.V. | 8.40B | -0.61% | 1,228,875 | 2.09B |
| 16 | ICLR | ICON Public Limited Company | 8.37B | -4.00% | 633,331 | 8.10B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.28B | -3.26% | 1,344,512 | 4.02B |
| 18 | RDNT | RadNet, Inc. | 4.27B | 0.49% | 587,994 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.23B | -0.60% | 3,464,923 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.93B | 7.74% | 347,594 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 3.14B | 1.93% | 672,474 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.57B | 0.22% | 411,638 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.12B | -5.91% | 818,475 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.95B | 0.62% | 458,908 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.04B | 0.25% | 1,710,343 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 912.68M | -2.68% | 290,512 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 895.70M | 3.51% | 2,715,951 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 735.25M | -0.44% | 201,589 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 688.78M | - | 701,886 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 473.63M | -2.38% | 329,179 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 436.68M | -1.68% | 609,569 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 335.90M | 1.42% | 129,612 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 175.50M | 0.62% | 14,662 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 151.42M | 1.92% | 97,143 | 88.50M |
| 35 | FONR | FONAR Corporation | 121.94M | 0.05% | 9,558 | 106.03M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 108.41M | -10.37% | 192,237 | 4.06M |
| 37 | MDXH | MDxHealth SA | 105.30M | -5.09% | 411,299 | 107.88M |
| 38 | XGN | Exagen Inc. | 74.08M | 0.65% | 162,014 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 46.34M | 2.28% | 53,642 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 18.79M | 6.63% | 1,409,946 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 12.46M | -6.04% | 65,006 | - |
| 42 | XWEL | XWELL, Inc. | 12.05M | 42.06% | 1,295,428 | 29.21M |
| 43 | NOTV | Inotiv, Inc. | 8.92M | -2.81% | 331,296 | 514.03M |
| 44 | ADVB | Advanced Biomed Inc. | 6.03M | -2.86% | 3,757,022 | - |
| 45 | QUCY | Mainz Biomed N.V. | 5.95M | 3.71% | 105,960 | 1.07M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.53M | 1.07% | 5,722 | - |
| 47 | ISPC | iSpecimen Inc. | 4.54M | 7.52% | 4,799,041 | 1.93M |